Format

Send to

Choose Destination
Cancer Cell. 2012 Sep 11;22(3):283-5. doi: 10.1016/j.ccr.2012.08.020.

Strategies for p53 reactivation in human sarcoma.

Author information

1
Institute of Genetics and Molecular Medicine, University of Edinburgh, UK. ted.hupp@ed.ac.uk

Abstract

Emerging strategies in cancer therapeutics link the genomic mutational and proteomic landscape, allowing intelligent reasoning on target selection. In this issue of Cancer Cell, Piccinin and colleagues use this approach to demonstrate that the mesenchymal protein Twist1 inhibits p53, providing a novel target for reactivation of p53 in human sarcoma.

PMID:
22975370
DOI:
10.1016/j.ccr.2012.08.020
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center